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INTRODUCTION
The principal use of extracorporeal circulation
(ECC) has been to facilitate operative procedures
involving the heart. A pump and oxygenator replace
the function of both the heart and lungs during sur-
gery, and open-heart procedures usually require both.
Although the efficacy of ECC in open-heart and aor-
tic surgery is well established, application of ECC
in other surgical areas has not been given much
attention. Complications associated with ECC tem-
pered the initial enthusiasm for non-cardiac appli-
cations. With time, however, a more reasoned ap-
proach to the use of ECC for noncardiovascular
applications came about, and many of the early prob-
lems and complications have been overcome. ECC
is beginning to be used for circulatory support or
tissue oxygenation during surgery on the lung, brain,
liver, and kidney as well as in emergency situations.
Recent applications are shown on Table 1. This re-
port outlines the current indications, technique, and
outcome during these surgical endeavors.
APPLICATIONS IN LUNG SURGERY
Although ECC is used primarily to facilitate car-
diac surgery, the lungs are also bypassed with ECC.
In fact, Gibbons developed his pump oxygenator in
1937 primarily to operate on patients with pulmo-
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nary embolism (1). In general, ECC is not needed
for lung surgery because one lung can support ven-
tilation while the other undergoes repair. However,
maintenance of ventilation may be inadequate dur-
ing extensive resection of the trachea or in other
special situations. When surgery is needed in this
part of the pulmonary system, ECC can make it
feasible. In addition, ECC is sometimes used for
circulatory support during lung surgery. Applications
of ECC during lung surgery are shown on Table 2.
Although midline sternotomy with cannulation of
the right atrium and ascending aorta is the preferred
protocol for ECC in cardiac surgery (2), certain
circumstances require the institution of bypass with
lower extremity access (3) - typically, femoro-femoral
bypass (4, 5) (Figure 1). The access site depends
primarily on the planned surgery, but femoro-femoral
bypass is used more often for ECC in case of non-
cardiac surgery (particularly lung surgery) than for
ECC in cardiac cases.
Table 1 Applications of extracorporeal circulation
Open-heart surgery
Aortic surgery
Lung surgery
For respiratory support
For circulatory support
Neurosurgery
Profound hypothermia and circulatory arrest
Liver surgery
Liver transplantation
Hepatectomy
Urologic surgery
Resection of renal cell carcinoma extending into the
inferior vena cava
Other
Emergency use
Supported PTCA
Malignant hyperthermia
Accidental hypothermia
PTCA : percutaneous transluminal coronary angioplasty
Figure 1. Veno-arterial bypass system consisting of a centrifugal blood pump and a hollow fiber membrane oxygenator. The ve-
nous catheter is inserted into the inferior vena cava through a femoral vein with the femoral artery serving as the inflow vessel.
Table 2 Applications of extracorporeal circulation during lung
surgery
Pulmonary embolectomy
Surgery on the lower trachea and carina
(Tracheocarinal resection, bronchofiberscopic laser sur-
gery, bronchial stenting, etc.)
Lung cancer, thyroid cancer, esophageal cancer, me-
diastinal tumor
Stenosis of the lower trachea due to old tuberculosis
Post tracheotomy stenosis, etc.
Lung transplantation
Descending aorta pathology (for circulatory support)
Severe respiratory dysfunction (for respiratory support)
Chest trauma
Tracheobronchial injury
Bilateral pneumothorax
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Pulmonary embolectomy
A major contribution of ECC in the field of lung
surgery has been in whole body perfusion during
pulmonary embolectomy. It was the lack of a rapid
effective treatment for moribund patients with pul-
monary embolus that led Gibbons (1) to begin his
pioneering work with ECC. Gibbons himself was
never able to treat such patients, but in 1961, Cooley,
et al. (6) performed emergency ECC in a patient with
a massive pulmonary embolus. In 1966, Rosenberg,
et al. (7) reviewed cases in which ECC was used
for pulmonary embolectomy and made several rec-
ommendations. They concluded that if pulmonary
embolectomy was to be successful, resection had
to be attempted within 2 hours of embolization.
It has been reported that the success rate of em-
bolectomy was only 33% for long-term survival (8).
However, many researchers concluded ECC to be
necessary because the mortality rate would other-
wise have been 100% without it. Garcia, et al.(9),
recognizing the importance of early ECC for resus-
citating patients, advocated partial bypass for resus-
citation, and in a combined approach, they used total
bypass for resection of the pulmonary embolus. Some
centers have later reported very good (84%) sur-
vival rates (10). Pulmonary catheter embolectomy
without ECC is a new technique that has been ad-
vocated for managing critically ill pulmonary em-
bolism patients, but its utility is still being investi-
gated (11).
Surgery on the lower trachea and carina
Surgery on the lower trachea involving the carina
presents special problems in maintaining a patient
airway and airtight seal for adequate ventilation.
Currently, use of ECC is not routine for carinal or
tracheal lesions. Repairs can be performed in most
cases without ECC. The current treatment strategy
for tracheal and carinal pathologies was pioneered
by Grillo, et al. at Massachusetts General Hospital.
They reported in 1969, 31 patients who had under-
gone tracheal resection during a 7-year period in
which bypass was not utilized (12). For tracheal le-
sions, anesthesia is induced, an oral endotracheal
tube is placed, the chest is opened, and the trachea
is transected distally ; the distal tracheal segment
is later intubated from within the operating field.
The tracheal lesion can then be resected and the
trachea reanastomosed. For more distal lesions,
including lesions of the carina, Grillo, et al. advo-
cated intubating one of the main bronchi from within
the operative field, with obstruction of the contra-
lateral pulmonary artery to optimize ventilation and
perfusion during resection of the carinal lesion. High
frequency jet ventilation is also often used (13, 14).
However, because distal airway obstruction can oc-
cur following induction of general anesthesia, ECC
should be considered as a viable alternative for pa-
tients at increased risk for this complication.
Many researchers have reported ECC manage-
ment of this complication (15-20). The first case in
which ECC was used for resection of the carina and
both main-stem bronchi for bronchial adenoma was
reported by Woods, et al. in 1961 (15). ECC was
considered the only means to achieve satisfactory
plastic repair of the excised carina. This was also the
first report of the use of ECC in lung surgery. Nis-
sen (16) used bypass combined with hypothermia
to aid in the resection of a malignant tracheal ade-
noma. In the third case, reported in 1964 by Adkins
and Izawa (17), a cylindroma was resected under
bypass. Soon after, Neville, et al. reported 14 sur-
geries under ECC that involved trachea, carina, or
major bronchi (18). Depending on the location of the
tumor, they used either a right, left, or anterior tho-
racotomy. They cannulated the superior vena cava
from the right atrium, drained the inferior vena cava
via femoral venous cannula, and returned the arte-
rialized blood via cannula in the femoral artery. Af-
ter these reports, several similar surgeries were per-
formed (19, 20). In 1983, the first report was pub-
lished on a percutaneous cannula, pump, and oxy-
genator system ; the percutaneous cardiopulmonary
support (PCPS) system (21). Almost all surgeons
now use femoro-femoral ECC during surgery on the
lower trachea and carina (22, 23). A right postero-
lateral or bilateral anterior thoracotomy is used for
resection of the trachea and for removal of the carina.
The tracheobronchial tree is completely mobilized,
and the pulmonary vessels are divided prior to
heparinization. Following mobilization of the lung
and its intrinsic architecture or isolation of the de-
scending aorta proximal and distal to the lesion, the
patient is heparinized and connected to the oxygena-
tor via catheter inserted into the femoral artery and
into the inferior vena cava from the femoral vein.
A technically interesting report was provided in
1996 by Horita, et al. (24), who used veno-venous
bypass with an oxygenator via a percutaneous femo-
ral venous approach to undertake carinal reconstruc-
tion. These authors placed bilateral femoral venous
cannulas and interposed a centrifugal pump and oxy-
genator. This was accomplished with partial heparini-
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zation to maintain an activated clotting time of greater
than 250 seconds.
ECC is also used when maintaining the upper
airway is difficult. Two situations are call for ECC
(especially PCPS) : difficulty in endotracheal intu-
bation and difficulty in maintaining the upper res-
piratory tract after the intubation. Bronchial fiber-
scopic laser surgery and bronchial stenting for the
treatment of tracheal stenosis or obstruction also
sometimes require PCPS. Many researchers em-
phasize the importance of having the PCPS machine
primed and readied and the patient’s groin prepared
before such procedures (15-17). If the patient’s air-
way becomes obstructed during the induction of
general anesthesia because of an intratracheal tu-
mor, PCPS can be instituted immediately.
Lung transplantation
Single-lung transplantation is most frequently per-
formed with the donor lung transplanted into the
recipient’s right chest. This can be achieved most
of the time without ECC. During resection of the
native lung, the contralateral lung is ventilated via
endotracheal tube inserted from within the opera-
tive field while the donor lung is implanted in the
chest and the pulmonary artery is anastomosed. In
some patients, however, it is impossible to provide
adequate gas exchange with one lung because of
underlying disease in the nonoperative lung. Cur-
rently, no good preoperative test is available to pre-
dict which patients with obstructive lung disease
will require ECC.
Preoperative prediction is possible, however, for
patients with restrictive lung disease. On the basis
of exercise tolerance and right ventricular ejection
fraction, it is possible to know which patients will
require intraoperative ECC (25). When ECC is
used, insertion of the arterial and venous cannulas
is usually through the groin, with the chest kept
free of cannulas for the sake of the transplant sur-
geon (26) ; however, many surgeons prefer a stan-
dard approach with the cannulas in the vena cava
and aortic root.
Descending aorta pathology : Lung cancer with
extension into the heart and the great vessels
Surgery for lung cancer or mediastinal tumor that
includes resection of the descending aorta is a good
application for ECC circulatory support. Left pneu-
monectomy and resection of the descending aorta
can be performed with ECC alone. There is also a
report of removal of a lung sarcoma with extension
into the left atrium that was successfully managed
with ECC (27).
Severe respiratory dysfunction during lung surgery
For the patient with severe preoperative respira-
tory dysfunction and the patient for whom severe
respiratory failure is expected intraoperatively, ECC
is sometimes used for respiratory support. Patients
undergoing further lung surgery after contralateral
total lung resection, patients undergoing lung sur-
gery who have old tuberculosis in the opposite lung,
and patients with severe emphysema are included
in this category.
Chest trauma
Injuries to the various intrathoracic structures play
a major role in morbidity and mortality related to
chest trauma (28). Most chest injuries, including
wounds to the heart and the aorta, can be repaired
without the aid of ECC. However, a few injuries of
the heart, the great vessels, and occasionally, the
major airway call for some form of ECC support.
Femoral ECC has been used for traumatic tracheal
disruption (29). Patients requiring ECC are usually
those who have suffered complex or extensive lon-
gitudinal tracheal rupture, and no other form of ade-
quate ventilatory and/or circulatory support can be
provided during the repair for them (30). In addi-
tion, bilateral pneumothorax, severe barotrauma,
and severe air leak require ECC to avoid positive
pressure ventilation. Therefore, when it is difficult
to provide adequate ventilation or circulatory sup-
port to patients during repair of airway injury, ECC
should be used.
APPLICATIONS IN NEUROSURGERY
The introduction of profound hypothermia and
circulatory arrest into complex neurosurgical pro-
cedures coincided with the refinement of this pro-
cedure in patients undergoing congenital cardiac or
aortic arch repair. ECC with profound hypothermia
and circulatory arrest became the preferred approach
to repairing a number of neurovascular abnormali-
ties. ECC is used to induce profound hypothermia
so that circulatory arrest can be instituted. This pro-
vides a bloodless surgical field for the repair of vas-
cular abnormalities such as intracranial aneurysm
and for resection of intracranial tumors. The use
of profound hypothermia and circulatory arrest in
a neurosurgery case was described initially in 1960
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by Woodhall, et al. (31). Circulatory arrest of 10
minutes at 4was used to facilitate drainage of a
large subcortical tumor cyst in a 39-year-old man
with metastatic carcinoma of the lung. Cannulation
for pulmonary bypass was via the femoral artery and
jugular vein. The patient recovered uneventfully from
the procedure yet succumbed to the pulmonary dis-
ease about 3 months later. Over the next several
years, a number of studies evaluating this method
for intracranial surgery were published (32-34).
The decrease in cerebral oxygen consumption af-
forded by profound hypothermia induced with pump
oxygenator bloodstream cooling permits total cir-
culatory arrest for removal of complicated intracere-
bral disease in bloodless field. Use of hypothermia
in intracranial surgery is based upon the premise
that lowering of the cerebral oxygen metabolism
rate of neuronal tissue by decreasing body tempera-
ture confers a measure of protection against cere-
bral ischemia. The cerebral oxygen metabolism rate
in humans is reduced to 50% of normal at 30, 15%
of normal at 20and to less than 10% of normal at
15(35). Several studies have demonstrated the
protective effect of profound hypothermia in the face
of cerebral ischemia (32).
When further intracranial surgery is not feasible
under conditions of spontaneous circulation, femo-
ral venous and artery cannulations are performed.
Partial bypass is initiated, and cooling is begun at
a rate of 0.2/min. Ventricular fibrillation will oc-
cur when core temperature is between 23and
27. Potassium chloride may be given in 20 mEq
boluses to achieve cardiac standstill. When the brain
temperature reaches 16 to 18, the pump is
stopped. During circulatory arrest, mobilization of
the aneurysm is completed, and ligation, clipping,
or aneurysmectomy is performed.
Advances in the last decade in the anesthetic
management of neurosurgery patients combined
with refinements in ECC techniques have encour-
aged several centers to re-evaluate the use of deep
hypothermia and circulatory arrest in the treatment
of selected complex intracranial lesions. Williams
(36) treated 10 patients with complex intracranial
pathologies ; i.e., aneurysm, arteriovenous malfor-
mation, glomus jugular tumor, and a cerebullar he-
mangioblastoma judged inoperable by conventional
methods. Eight of the 10 patients achieved an ex-
cellent outcome. Solomon (37) reviewed 14 patients
operated on for giant anterior or posterior circula-
tion aneurysm. There were no operative deaths in
this series. Later, many researchers have reported
good or excellent outcomes (38-40). The majority
of the more recent reports suggest that a core tem-
perature of 15will provide up to 60 min of safe
ischemia time during circulatory arrest.
APPLICATIONS IN LIVER SURGERY
Veno-venous bypass can also be used in the man-
agement of some liver surgeries, most frequently
liver transplantation during the anhepatic phase and
combined resection of the liver or kidney and vena
cava. Veno-venous bypass re-establishes blood re-
turn between the surgically obstructed vena cava
and portal vein to the central venous circulation via
the axillary vein. The circuit is composed of drain-
age cannula in the obstructed vessels (blood drained
by gravity) and a centrifugal pump that pumps blood
into the axillary vein via the return cannula.
Liver transplantation
Every year, many patients die of liver failure. For
some patients, liver transplantation is a viable and
life-saving option. The principal use of veno-venous
bypass is in certain cases of hepatic transplantation ;
the majority of liver transplant centers have utilized
veno-venous bypass for many years (41-48).
The phase of surgery during which mobilization
and removal of the native liver occurs and the an-
hepatic phase remain the most crucial periods in
the transplantation procedure. During these peri-
ods, surgical obstruction of the inferior vena cava
and portal vein is necessary. The subsequent in-
terruption of venous return to the heart is often as-
sociated with an up to 50% reduction in cardiac
output and marked increase in systemic vascular
resistance (41). In an attempt to maintain closer to
normal hemodynamics during the anhepatic phase,
Calne, et al. (42) first used partial ECC. Incorpora-
tion of veno-venous bypass during liver transplan-
tation allows for maintenance of venous return and
cardiac filling pressures during inferior vena cava
occlusion. Additionally, veno-venous bypass may be
especially useful in elderly patients with cholecys-
tic disease and pulmonary hypertension, since this
group is particularly prone to hemodynamic insta-
bility with caval occlusion (43).
Renal function is also compromised during the
anhepatic phase of liver transplantation. Caval oc-
clusion results in decreased systemic arterial blood
pressure and in elevation of renal venous pressure
(44). Because veno-venous bypass improves renal
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blood flow by maintenance of an adequate preload,
cardiac output, and normal renal vein pressure,
some believe that the use of bypass will reduce the
incidence of postoperative renal dysfunction (45).
Further benefits of veno-venous bypass include safe
extension of the venous occlusion period during
more complicated procedures and in training situ-
ations. Veno-venous bypass has been suggested also
to result in decreased intraoperative blood loss.
Hepatectomy
ECC is indicated for combined hepatic and vena
caval resection (49-53). It is often impossible to
isolate the liver and achieve acceptable cancer-free
margins without resecting the inferior vena cava,
and it is difficult to maintain arterial blood pressure
without ECC. During combined liver and vena caval
resection, decompression of the portal system is
not necessary. Cross-clamp time is usually only 15
to 30 min, and it would be unusual for the bowel and
mesentery not to tolerate venous outflow obstruc-
tion for this brief period. It is necessary, however,
to shunt the lower systemic circulation. In these
circumstances, the systemic circulation is drained via
inferior vena cava catheter, and the venous effluent
is returned to the patient by internal jugular can-
nula.
APPLICATIONS IN UROLOGIC SURGERY
The surgical treatment of renal cell tumors with
intracardiac and intravenacaval tumor thrombi is very
difficult and requires temporary adjuncts to prevent
both ischemia of the visceral organs and pulmonary
thrombi during tumor extirpation. For protecting of
the visceral organs from ischemia, ECC is usually
used. It has been recognized for some time that pa-
tients with renal cell carcinoma extending into the
inferior vena cava have a poor prognosis, but if the
tumor can be resected in its entirely, the prognosis
is improved.
Tongaonker, et al. (54) reported 4 types of renal
cell carcinoma extending into the inferior vena cava :
the renal vein thrombus, the intrahepatic intra-
venacaval thrombus, the retrohepatic intravenacaval
thrombus, and the suprahepatic intravenacaval throm-
bus. Surgery and ECC methods differ between these
4 types. The main indication for ECC in urologic
surgery is resection of renal tumors, primarily re-
nal cell carcinoma or hypernephroma that extends
into the inferior vena cava superiorly past the dia-
phragm. Tumors not extending above the diaphragm
or into the right atrium can frequently be resected
by surgical methods not requiring bypass. Depend-
ing on the extent of the tumor, veno-venous bypass
can occasionally be used to shunt blood from the
inferior to the superior vena cava. Veno-venous by-
pass with a centrifugal pump or partial cardiopul-
monary bypass with femoral arterial and venous
cannulation is used. ECC is necessary to open the
right atrium for the resection of intra-atrial tumor
thrombi. Although a more conservative surgery is
desirable for the removal of tumor thrombi, hepatic
mobilization is necessary for venous clamping of
the suprahepatic vena cava in cases requiring veno-
venous bypass or partial cardiopulmonary bypass
via femoro-femoral cannulation. Hepatic mobilization
and taping of the inferior vena cava is very danger-
ous in cases with tumor thrombi in the intrahepatic
or suprahepatic vena cava. Some institutions use
deep hypothermia and circulatory arrest.
Marshall, et al. (55) in 1970 used passive veno-
venous bypass to manage a patient with renal cell
carcinoma extending into the inferior vena cava
and right atrium. The need for a shunt that could
drain blood from the lower extremities and portal
system was obvious in the 1960s, but the first clini-
cal trials of bypass without a pump for patients with
liver disease were unsuccessful. The second report
of bypass used in urologic surgery was of a patient
with a right atrial tumor (56). After that, several in-
stances were reported in which ECC was used dur-
ing resection of renal cell carcinoma extending into
the right atrium (57-60).
OTHER APPLICATIONS
There are a number of unusual conditions for
which the use of bypass may be beneficial during
treatment. Broad categories of use of emergency
ECC (PCPS) include assisted interventions in the
catheterization laboratory and resuscitation of pa-
tients with cardiac arrest, severe hypotherma, pul-
monary embolism, or multiple trauma.
Emergency use
Emergency cardiopulmonary support has been
used as a resuscitative adjunct in several reported
groups of patients. Traditional ECC involves a well-
planned major surgical intervention. Emergency sup-
portive PCPS via the femoral artery and veins is also
an accepted technique. Percutaneous cannulas can
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be placed rapidly by the Seldinger technique, pro-
vide adequate systemic flow and venous drainage to
decompress the heart. Commercial compact portable
bypass systems (Figure 2) have been developed that
use centrifugal pumps without venous reservoirs.
The first percutaneous use of ECC was described
by Phillips, et al. (21) in 1983. PCPS is now widely
used for resuscitation (61, 62). Many indications,
such as pulmonary embolism, multiple trauma (in-
cluding cardiac wounds, aortic wounds, or major air-
way injuries), severe exposure hypothermia, and
malignant hyperthermia, have been reported. Re-
garding pulmonary embolism and multiple trauma,
they were described at the previous section in de-
tail. Needless to say, earlier initiation of PCPS is
the only way to rescue these patients.
Percutaneous transluminal coronary angioplasty
(PTCA)
Kanter, et al. (63) incorporated PCPS as a resus-
citative tool into the catheterization laboratory in
1988. After that, many researchers reported PCPS
as an adjunct measure in interventional cardiology
procedures such as cardiac catheterization and an-
gioplasty. The National Registry for Supported An-
gioplasty began accumulating data in 1988 on pa-
tients undergoing elective supported angioplasty ;
the database now includes patients given standby
supported PTCA (64), and data was published in
1994 for 801 enrolled patients (65).
Malignant hyperthermia
Before the clinical use of dantrolene, malignant
hyperthermia was treated with support therapies
including hyperventilation and systemic cooling of
the patient. In one case in which such maneuvers
were unsuccessful, ECC with hypothermia was suc-
cessfully instituted via a femolo-femoral approach
(66).
Accidental hypothermia
ECC with active rewarming has been used to sal-
vage patients with severe hypothermia secondary
to environmental exposure. Because many of these
patients die as a result of ventricular dysrhythmia
or circulatory collapse, ECC is an attractive rewarm-
ing method. In 1967, Kugelberg, et al. (67) described
the management of a patient who arrived at their
hospital with a core body temperature of 21.7.
Because of concerns about gradually warming the
patient and the risk of cardiac arrest resulting from
ventricular fibrillation, the authors rewarmed the
patient rapidly under bypass in which a heart ex-
changer and oxygenator were used. Cannulation was
via the left femoral artery and vein. The patient was
successfully rewarmed without development of ven-
tricular fibrillation.
Several reported studies have examined the use
of ECC in accidental hypothermia. Hauty, et al.
(68) reported 11 patients that were admitted to the
hospital emergency department profoundly hypother-
mic ; 10 were warmed via bypass, and there were 2
long-term survivors. The rapid femoral cannulation
techniques should lead to greater utilization and eas-
ier application of ECC in this type of patient (69).
COMPLICATIONS
Patients undergoing ECC for non-cardiac appli-
Figure 2. Commercial compact portable bypass systems
Left : Capiox Emergency Bypass System (EBS) (Terumo Inc., Tokyo, Japan)
Right : Carmeda Closed Chest Support System (CCSS) (Medtronic Cardiopulmonary Division, Anaheim, CA)
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cations experience similar complications to those
of cardiac surgical patients. Neurologic, pulmonary,
renal, gastrointestinal, cardiac, bleeding, immu-
nologic, and infectious complications are probably
as prevalent in the non-cardiac populations as in the
“traditional” patient population. Also, the use of
femoral arterial cannulation adds the potential for
hypoperfusion, dissection of the great arteries, and
vascular or neurologic injury to the lower extrem-
ity (70).
CONCLUSION
Success with ECC for repair of cardiac anoma-
lies has stimulated consideration of its potential for
assisting with the surgical management of other
disease conditions. The use of ECC in selected high-
risk patients may provide for safe treatment of com-
plex non-cardiac lesions that could not otherwise
be approached. The use of ECC during non-cardiac
surgery is expanding rapidly because of its increas-
ing availability. Despite the fact that mortality rates
have been high in non-cardiac surgery patients
treated under ECC, all had conditions that would
have been inevitably fatal without surgery. In no
instance was the incorporation of ECC responsible
for the death of a patient. In fact, without ECC ade-
quate extirpation of the disease could not have
been accomplished. It is important that the sur-
geon, anesthesiologist, and perfusionist have ade-
quate experience in the use of these techniques,
which is frequently gained in the application of
ECC during non-cardiac procedures. A well-trained,
experienced, and knowledgeable team significantly
improves patient outcome.
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